A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study
一项针对去势敏感性前列腺癌的帕唑帕尼随机II期研究:芝加哥大学II期临床试验联盟/美国国防部前列腺癌临床试验联盟研究
期刊:Prostate Cancer and Prostatic Diseases
影响因子:5.8
doi:10.1038/pcan.2011.49
Ward, J E; Karrison, T; Chatta, G; Hussain, M; Shevrin, D; Szmulewitz, R Z; O'Donnell, P H; Stadler, W M; Posadas, E M